Altogether, our data allowed us to classify the large panel of eleven DLBCL cell lines for their metabolic OxPhos vs. glycolytic status as well as for their BCR vs. non-BCR status (Figure 1d). The gene discussed is BCR; the disease is diffuse large B-cell lymphoma.